相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Study of the anti-JCV antibody levels in a Spanish multiple sclerosis cohort
Maria I. Dominguez-Mozo et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2017)
Selection of first-line therapy in multiple sclerosis using risk-benefit decision analysis
David Bargiela et al.
NEUROLOGY (2017)
Anti-JC virus seroprevalence in a Finnish MS cohort
M. Kolasa et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
PML risk stratification using anti-JCV antibody index and L-selectin
Nicholas Schwab et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
PML risk stratification using anti-JCV antibody index and L-selectin
Nicholas Schwab et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
High cumulative JC virus seroconversion rate during long-term use of natalizumab
A. Vennegoor et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern study
Raed Alroughani et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
Observational data: Understanding the real MS world
Tomas Kalincik et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Teaching Video NeuroImages: Daytime sleepiness and automatic behavior due to severe restless legs syndrome
Anastasios Bonakis et al.
NEUROLOGY (2016)
NATALIZUMAB-RELATED PML 2 WEEKS AFTER NEGATIVE ANTI-JCV ANTIBODY ASSAY
Daniel Ontaneda et al.
NEUROLOGY (2016)
Observational data: Understanding the real MS world
Tomas Kalincik et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values
Nicholas Schwab et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS
Tim Spelman et al.
NEUROLOGY-CLINICAL PRACTICE (2016)
Lipid-Specific Immunoglobulin M Bands in Cerebrospinal Fluid Are Associated with a Reduced Risk of Developing Progressive Multifocal Leukoencephalopathy during Treatment with Natalizumab
Luisa M. Villar et al.
ANNALS OF NEUROLOGY (2015)
Persistence and Pathogenesis of the Neurotropic Polyomavirus JC
Hassen S. Wollebo et al.
ANNALS OF NEUROLOGY (2015)
Anti-JC virus antibody titres increase over time with natalizumab treatment
J. Raffel et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
PML: The Dark Side of Immunotherapy in Multiple Sclerosis
Clemens Warnke et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Anti-JC virus antibody titres increase over time with natalizumab treatment
J. Raffel et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
JC virus urinary excretion and seroprevalence in natalizumab-treated multiple sclerosis patients
Serena Delbue et al.
JOURNAL OF NEUROVIROLOGY (2015)
Anti-JC Virus Antibody Levels in Serum or Plasma Further Define Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
Tatiana Plavina et al.
ANNALS OF NEUROLOGY (2014)
Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial
C. Bozic et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Seroprevalence Rates of BKV, JCV, and MCPyV Polyomaviruses in the General Czech Republic Population
Vojtech Sroller et al.
JOURNAL OF MEDICAL VIROLOGY (2014)
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab
Olivier Outteryck et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
High discontinuation rate of natalizumab in JC virus seropositive patients due to significant anxiety and safety feelings
R. Alroughani
MULTIPLE SCLEROSIS JOURNAL (2014)
JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants
Emilie Sundqvist et al.
PLOS PATHOGENS (2014)
JC Virus Antibody Status Underestimates Infection Rates
Joseph R. Berger et al.
ANNALS OF NEUROLOGY (2013)
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification
Peter Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Anti-JCV Antibodies Detection and JCV DNA Levels in PBMC, Serum and Urine in a Cohort of Spanish Multiple Sclerosis Patients Treated with Natalizumab
Maria Inmaculada Dominguez-Mozo et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Changes to anti-JCV antibody levels in a Swedish national MS cohort
Clemens Warnke et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes
David B. Clifford et al.
JOURNAL OF NEUROVIROLOGY (2013)
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort
Tomas Olsson et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?
Joachim Havla et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2013)
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort
A. K. Trampe et al.
NEUROLOGY (2012)
Neutralization Serotyping of BK Polyomavirus Infection in Kidney Transplant Recipients
Diana V. Pastrana et al.
PLOS PATHOGENS (2012)
Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: Baseline results of STRATIFY-1
Carmen Bozic et al.
ANNALS OF NEUROLOGY (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Anti-JC Virus Antibodies: Implications for PML Risk Stratification
Leonid Gorelik et al.
ANNALS OF NEUROLOGY (2010)
Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians
Annika Antonsson et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors
Adrian Egli et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Brief report - Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis
BK Kleinschmidt-DeMasters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Brief report - Progressive multifocal leukoencephalopathy in a patient treated with natalizumab
A Langer-Gould et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Brief report - Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease
G Van Assche et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy
RA Du Pasquier et al.
BRAIN (2004)
Viral regulatory region sequence variations in kidney tissue obtained from patients with BK virus nephropathy
P Randhawa et al.
KIDNEY INTERNATIONAL (2003)
The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: Study of 43 cases with review of the literature
P Cinque et al.
JOURNAL OF NEUROVIROLOGY (2003)
分享论文
